BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Häussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008;57:1156-65. [PMID: 18628377 DOI: 10.1136/gut.2007.122176] [Cited by in Crossref: 253] [Cited by in F6Publishing: 213] [Article Influence: 18.1] [Reference Citation Analysis]
Number Citing Articles
1 Klose J, Goerg B, Berndt C, Häussinger D, Aktas O, Prozorovski T. Protein oxidative damage in the hippocampus in a mouse model of acute hyperammonemia. Eur J Med Res 2014;19. [DOI: 10.1186/2047-783x-19-s1-s29] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Popek M, Bobula B, Sowa J, Hess G, Polowy R, Filipkowski RK, Frontczak-Baniewicz M, Zabłocka B, Albrecht J, Zielińska M. Cortical Synaptic Transmission and Plasticity in Acute Liver Failure Are Decreased by Presynaptic Events. Mol Neurobiol 2018;55:1244-58. [PMID: 28116546 DOI: 10.1007/s12035-016-0367-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 Adlimoghaddam A, Sabbir MG, Albensi BC. Ammonia as a Potential Neurotoxic Factor in Alzheimer's Disease. Front Mol Neurosci 2016;9:57. [PMID: 27551259 DOI: 10.3389/fnmol.2016.00057] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
4 Jamshidzadeh A, Heidari R, Latifpour Z, Ommati MM, Abdoli N, Mousavi S, Azarpira N, Zarei A, Zarei M, Asadi B, Abasvali M, Yeganeh Y, Jafari F, Saeedi A, Najibi A, Mardani E. Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic rats. Clin Res Hepatol Gastroenterol 2017;41:424-34. [PMID: 28283328 DOI: 10.1016/j.clinre.2016.12.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
5 Prakash RK, Kanna S, Mullen KD. Evolving Concepts: The Negative Effect of Minimal Hepatic Encephalopathy and Role for Prophylaxis in Patients With Cirrhosis. Clinical Therapeutics 2013;35:1458-73. [DOI: 10.1016/j.clinthera.2013.07.421] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
6 Hsu S, Hsin I, Lin Y, Chen Y, Huang H, Lee F, Lin H, Chang C, Lee S. The influence of sorafenib on hepatic encephalopathy and the mechanistic survey in cirrhotic rats: INFLUENCE OF SORAFENIB ON HEPATIC ENCEPHALOPATHY. European Journal of Clinical Investigation 2012;42:1309-16. [DOI: 10.1111/eci.12006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
7 Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. Journal of Hepatology 2015;63:1272-84. [DOI: 10.1016/j.jhep.2015.07.004] [Cited by in Crossref: 272] [Cited by in F6Publishing: 231] [Article Influence: 38.9] [Reference Citation Analysis]
8 Palomero-Gallagher N, Zilles K. Neurotransmitter receptor alterations in hepatic encephalopathy: a review. Arch Biochem Biophys 2013;536:109-21. [PMID: 23466244 DOI: 10.1016/j.abb.2013.02.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
9 Bajaj JS, Heuman DM, Sanyal AJ, Hylemon PB, Sterling RK, Stravitz RT, Fuchs M, Ridlon JM, Daita K, Monteith P, Noble NA, White MB, Fisher A, Sikaroodi M, Rangwala H, Gillevet PM. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One. 2013;8:e60042. [PMID: 23565181 DOI: 10.1371/journal.pone.0060042] [Cited by in Crossref: 227] [Cited by in F6Publishing: 220] [Article Influence: 25.2] [Reference Citation Analysis]
10 Biselli M, Gitto S, Gramenzi A, Di Donato R, Brodosi L, Ravaioli M, Grazi GL, Pinna AD, Andreone P, Bernardi M. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? Liver Transpl. 2010;16:964-973. [PMID: 20677287 DOI: 10.1002/lt.22093] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
11 Merli M, Lucidi C, Pentassuglio I, Giannelli V, Giusto M, Di Gregorio V, Pasquale C, Nardelli S, Lattanzi B, Venditti M. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections. J Hepatol. 2013;59:243-250. [PMID: 23523580 DOI: 10.1016/j.jhep.2013.03.012] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
12 Sun Z, Liu YD, Lv CL, Zhong RG. Theoretical investigation of the isomerization of N2O3 and the N-nitrosation of dimethylamine by asym-N2O3, sym-N2O3, and trans–cis N2O3 isomers. Journal of Molecular Structure: THEOCHEM 2009;908:107-13. [DOI: 10.1016/j.theochem.2009.05.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
13 Malaguarnera M, Vacante M, Motta M, Giordano M, Malaguarnera G, Bella R, Nunnari G, Rampello L, Pennisi G. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metab Brain Dis 2011;26:281-9. [DOI: 10.1007/s11011-011-9260-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
14 Kruczek C, Görg B, Keitel V, Bidmon HJ, Schliess F, Häussinger D. Ammonia increases nitric oxide, free Zn(2+), and metallothionein mRNA expression in cultured rat astrocytes. Biol Chem 2011;392:1155-65. [PMID: 22050230 DOI: 10.1515/BC.2011.199] [Reference Citation Analysis]
15 Solà E, Cárdenas A, Ginès P. Hyponatremia in Cirrhosis: Evaluation and Treatment. In: Simon EE, editor. Hyponatremia. New York: Springer; 2013. pp. 145-57. [DOI: 10.1007/978-1-4614-6645-1_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Bai M, Yang Z, Qi X, Fan D, Han G. l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2013;28:783-792. [PMID: 23425108 DOI: 10.1111/jgh.12142] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
17 Zhou Y, Dong Q, Zhang R, Zhou S, Li L, Cheng K, Kong R, Yu Q, Xu S, Li J, Li S, Feng J, Wu L, Liu T, Lu X, Chen K, Xia Y, Lu J, Zhou Y, Guo C. Cerebral Hemodynamics and Cognitive Function in Cirrhotic Patients with Hepatic Encephalopathy. Gastroenterol Res Pract 2016;2016:8485032. [PMID: 28096811 DOI: 10.1155/2016/8485032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
18 Gã¶rg B, Morwinsky A, Keitel V, Qvartskhava N, Schrã¶r K, Hã¤ussinger D. Ammonia triggers exocytotic release of L-glutamate from cultured rat astrocytes. Glia 2009. [DOI: 10.1002/glia.20955] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 0.4] [Reference Citation Analysis]
19 Brunser AM, Illanes S, Lavados PM, Muñoz P, Cárcamo D, Hoppe A, Olavarria VV, Delgado I, Díaz V. Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study. J Stroke Cerebrovasc Dis 2013;22:1140-5. [PMID: 23253534 DOI: 10.1016/j.jstrokecerebrovasdis.2012.10.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
20 Rama Rao KV, Norenberg MD. Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy. Neurochem Int. 2012;60:697-706. [PMID: 21989389 DOI: 10.1016/j.neuint.2011.09.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
21 Mardini H, Smith FE, Record CO, Blamire AM. Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia. J Hepatol. 2011;54:1154-1160. [PMID: 21145802 DOI: 10.1016/j.jhep.2010.09.030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
22 Görg B, Schliess F, Häussinger D. Osmotic and oxidative/nitrosative stress in ammonia toxicity and hepatic encephalopathy. Arch Biochem Biophys. 2013;536:158-163. [PMID: 23567841 DOI: 10.1016/j.abb.2013.03.010] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
23 Riggio O, Ridola L, Pasquale C. Hepatic encephalopathy therapy: An overview. World J Gastrointest Pharmacol Ther 2010; 1(2): 54-63 [PMID: 21577297 DOI: 10.4292/wjgpt.v1.i2.54] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
24 Wunderlich F, Al-Quraishy S, Dkhil MA. Liver-inherent immune system: its role in blood-stage malaria. Front Microbiol 2014;5:559. [PMID: 25408684 DOI: 10.3389/fmicb.2014.00559] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
25 Buob S, Johnston AN, Webster CR. Portal hypertension: pathophysiology, diagnosis, and treatment. J Vet Intern Med. 2011;25:169-186. [PMID: 21382073 DOI: 10.1111/j.1939-1676.2011.00691.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
26 Kim SE, Park JW, Kim HS, Jang MK, Suk KT, Kim DJ. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure. Int J Mol Sci 2021;22:11680. [PMID: 34769109 DOI: 10.3390/ijms222111680] [Reference Citation Analysis]
27 Schliess F, Hoehme S, Henkel SG, Ghallab A, Driesch D, Böttger J, Guthke R, Pfaff M, Hengstler JG, Gebhardt R, Häussinger D, Drasdo D, Zellmer S. Integrated metabolic spatial‐temporal model for the prediction of ammonia detoxification during liver damage and regeneration. Hepatology 2014;60:2040-51. [DOI: 10.1002/hep.27136] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 8.3] [Reference Citation Analysis]
28 Miranda-bautista J, Bañares R, Vaquero J. The Gastrointestinal System. Gastrointestinal Tissue. Elsevier; 2017. pp. 3-20. [DOI: 10.1016/b978-0-12-805377-5.00001-1] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
29 Bai M, He C, Yin Z, Niu J, Wang Z, Qi X, Liu L, Yang Z, Guo W, Tie J, Bai W, Xia J, Cai H, Wang J, Wu K, Fan D, Han G. Randomised clinical trial: l -ornithine- l -aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. Aliment Pharmacol Ther 2014;40:63-71. [DOI: 10.1111/apt.12795] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
30 Ommati MM, Jamshidzadeh A, Niknahad H, Mohammadi H, Sabouri S, Heidari R, Abdoli N. N-acetylcysteine treatment blunts liver failure-associated impairment of locomotor activity. PharmaNutrition 2017;5:141-7. [DOI: 10.1016/j.phanu.2017.10.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
31 Butz M, May ES, Häussinger D, Schnitzler A. The slowed brain: Cortical oscillatory activity in hepatic encephalopathy. Archives of Biochemistry and Biophysics 2013;536:197-203. [DOI: 10.1016/j.abb.2013.04.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
32 Qi R, Zhang LJ, Zhong J, Zhang Z, Ni L, Zheng G, Lu GM. Disrupted thalamic resting-state functional connectivity in patients with minimal hepatic encephalopathy. Eur J Radiol. 2013;82:850-856. [PMID: 23332976 DOI: 10.1016/j.ejrad.2012.12.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
33 Rivera-mancía S, Tristán-lópez L, Montes S. Reactive Nitrogen and Oxygen Species in Hepatic Encephalopathy. Liver Pathophysiology. Elsevier; 2017. pp. 485-500. [DOI: 10.1016/b978-0-12-804274-8.00037-0] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
34 Schwarz C, Ferrea S, Quasthoff K, Walter J, Görg B, Häussinger D, Schnitzler A, Hartung H, Dihné M. Ammonium chloride influences in vitro-neuronal network activity. Experimental Neurology 2012;235:368-73. [DOI: 10.1016/j.expneurol.2012.02.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
35 Lazar M, Butz M, Baumgarten TJ, Füllenbach ND, Jördens MS, Häussinger D, Schnitzler A, Lange J. Impaired Tactile Temporal Discrimination in Patients With Hepatic Encephalopathy. Front Psychol 2018;9:2059. [PMID: 30425672 DOI: 10.3389/fpsyg.2018.02059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
36 Sauerbruch T, Appenrodt B, Schmitz V, Spengler U. The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosis. Dtsch Arztebl Int 2013;110:126-32, I. [PMID: 23505400 DOI: 10.3238/arztebl.2013.0126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
37 Kanimozhi S, Subramanian P, Shanmugapriya S, Sathishkumar S. Role of Bioflavonoid Quercetin on Expression of Urea Cycle Enzymes, Astrocytic and Inflammatory Markers in Hyperammonemic Rats. Indian J Clin Biochem 2017;32:68-73. [PMID: 28149015 DOI: 10.1007/s12291-016-0575-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
38 Baumgarten TJ, Neugebauer J, Oeltzschner G, Füllenbach ND, Kircheis G, Häussinger D, Lange J, Wittsack HJ, Butz M, Schnitzler A. Connecting occipital alpha band peak frequency, visual temporal resolution, and occipital GABA levels in healthy participants and hepatic encephalopathy patients. Neuroimage Clin 2018;20:347-56. [PMID: 30109194 DOI: 10.1016/j.nicl.2018.08.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
39 Shen YC, Chang YH, Fang CJ, Lin YS. Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis. Nutr J 2019;18:34. [PMID: 31279342 DOI: 10.1186/s12937-019-0461-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
40 Wilson KD, Ochoa LF, Solomon OD, Pal R, Cardona SM, Carpio VH, Keiser PH, Cardona AE, Vargas G, Stephens R. Elimination of intravascular thrombi prevents early mortality and reduces gliosis in hyper-inflammatory experimental cerebral malaria. J Neuroinflammation 2018;15:173. [PMID: 29866139 DOI: 10.1186/s12974-018-1207-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
41 Hung TH, Tseng CW, Tseng KC, Hsieh YH, Tsai CC, Tsai CC. Effect of renal function impairment on the mortality of cirrhotic patients with hepatic encephalopathy: a population-based 3-year follow-up study. Medicine (Baltimore) 2014;93:e79. [PMID: 25255022 DOI: 10.1097/MD.0000000000000079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
42 Hsieh H, Lue K, Kao CK, Hsu Y, Liu M, Kao P. Portosystemic Collateral Circulation: Demonstrated by Tc-99m–RBC SPECT/CT. Clinical Nuclear Medicine 2009;34:958-9. [DOI: 10.1097/rlu.0b013e3181bed007] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
43 Lu L, Wang J, Zhang L, Zhang Z, Ni L, Qi R, Kong X, Lu M, Sami MU, Xu K, Lu G. Disrupted metabolic and functional connectivity patterns of the posterior cingulate cortex in cirrhotic patients: a study combining magnetic resonance spectroscopy and resting-state functional magnetic resonance imaging. NeuroReport 2018;29:993-1000. [DOI: 10.1097/wnr.0000000000001063] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
44 Shaw J, Bajaj JS. Covert Hepatic Encephalopathy: Can My Patient Drive? J Clin Gastroenterol 2017;51:118-26. [PMID: 28027071 DOI: 10.1097/MCG.0000000000000764] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
45 Qu J, Lü X. Hydrogen: a promising novel treatment for hepatic encephalopathy? Free Radic Biol Med. 2013;63:457-458. [PMID: 23743290 DOI: 10.1016/j.freeradbiomed.2013.05.032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
46 Savlan I, Liakina V, Valantinas J. Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy. Medicina (Kaunas). 2014;50:75-81. [PMID: 25172600 DOI: 10.1016/j.medici.2014.06.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
47 Basu PP, Shah NJ. Clinical and Neurologic Manifestation of Minimal Hepatic Encephalopathy and Overt Hepatic Encephalopathy. Clin Liver Dis. 2015;19:461-472. [PMID: 26195201 DOI: 10.1016/j.cld.2015.05.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
48 Poh Z, Chang PE. A current review of the diagnostic and treatment strategies of hepatic encephalopathy. Int J Hepatol. 2012;2012:480309. [PMID: 23133760 DOI: 10.1155/2012/480309] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
49 Martínez Moreno B, Bellot P, de España F, Palazón JM, Such J, Pérez-Mateo M. [Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report]. Gastroenterol Hepatol 2011;34:468-73. [PMID: 21652116 DOI: 10.1016/j.gastrohep.2011.03.021] [Reference Citation Analysis]
50 Sheen JM, Chen YC, Hsu MH, Tain YL, Yu HR, Huang LT. Combined Intraperitoneal and Intrathecal Etanercept Reduce Increased Brain Tumor Necrosis Factor-Alpha and Asymmetric Dimethylarginine Levels and Rescues Spatial Deficits in Young Rats after Bile Duct Ligation. Front Cell Neurosci 2016;10:167. [PMID: 27445694 DOI: 10.3389/fncel.2016.00167] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
51 Córdoba J, Ventura-cots M. Drug-induced removal of nitrogen derivatives in urine: A new concept whose time has come: Cordoba and Ventura-Cots. Hepatology 2014;59:764-6. [DOI: 10.1002/hep.26789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
52 Munukutla S, Pan G, Deshpande M, Thandavarayan RA, Krishnamurthy P, Palaniyandi SS. Alcohol Toxicity in Diabetes and Its Complications: A Double Trouble? Alcohol Clin Exp Res 2016;40:686-97. [PMID: 27013182 DOI: 10.1111/acer.13008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
53 Wen S, Schroeter A, Klöcker N. Synaptic plasticity in hepatic encephalopathy - a molecular perspective. Arch Biochem Biophys 2013;536:183-8. [PMID: 23624147 DOI: 10.1016/j.abb.2013.04.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
54 Kappus MR, Bajaj JS. Covert hepatic encephalopathy: Not as minimal as you might think. Clin Gastroenterol Hepatol. 2012;10:1208-1219. [PMID: 22728384 DOI: 10.1016/j.cgh.2012.05.026] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
55 Thomsen KL, De Chiara F, Rombouts K, Vilstrup H, Andreola F, Mookerjee RP, Jalan R. Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis. Med Hypotheses 2018;113:91-7. [PMID: 29523305 DOI: 10.1016/j.mehy.2018.02.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
56 Wang P, Huang G, Tam N, Wu C, Fu S, Hughes BP, Wu L, He X. Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation. Eur J Gastroenterol Hepatol 2016;28:1210-5. [PMID: 27362549 DOI: 10.1097/MEG.0000000000000690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
57 Heidari R, Jamshidzadeh A, Ghanbarinejad V, Ommati MM, Niknahad H. Taurine supplementation abates cirrhosis-associated locomotor dysfunction. Clin Exp Hepatol 2018;4:72-82. [PMID: 29904723 DOI: 10.5114/ceh.2018.75956] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
58 Jiang X, Xu L, Tang L, Liu F, Chen Z, Zhang J, Chen L, Pang C, Yu X. Role of the indoleamine-2,3-dioxygenase/kynurenine pathway of tryptophan metabolism in behavioral alterations in a hepatic encephalopathy rat model. J Neuroinflammation 2018;15:3. [PMID: 29301550 DOI: 10.1186/s12974-017-1037-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
59 Faropoulos K, Chroni E, Assimakopoulos SF, Mavrakis A, Stamatopoulou V, Toumpeki C, Drainas D, Grintzalis K, Papapostolou I, Georgiou CD. Altered occludin expression in brain capillaries induced by obstructive jaundice in rats. Brain Res. 2010;1325:121-127. [PMID: 20170644 DOI: 10.1016/j.brainres.2010.02.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
60 Oria M, Jalan R. Brain lactate in hepatic encephalopathy: friend or foe? J Hepatol. 2014;60:476-477. [PMID: 24308990 DOI: 10.1016/j.jhep.2013.11.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
61 Deitmer JW, Rose CR. Ion changes and signalling in perisynaptic glia. Brain Research Reviews 2010;63:113-29. [DOI: 10.1016/j.brainresrev.2009.10.006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
62 Muriel P, Fernández-martínez E, Montes S. Complications of Cirrhosis. Liver Pathophysiology. Elsevier; 2017. pp. 427-33. [DOI: 10.1016/b978-0-12-804274-8.00033-3] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
63 Brunelli L, Campagna R, Airoldi L, Cauli O, Llansola M, Boix J, Felipo V, Pastorelli R. Exploratory investigation on nitro- and phospho-proteome cerebellum changes in hyperammonemia and hepatic encephalopathy rat models. Metab Brain Dis 2012;27:37-49. [DOI: 10.1007/s11011-011-9268-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Varakanahalli S, Sharma BC, Srivastava S, Sachdeva S, Dahale AS. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo. Eur J Gastroenterol Hepatol 2018;30:951-8. [PMID: 29727385 DOI: 10.1097/MEG.0000000000001137] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
65 Koziarska D, Wunsch E, Milkiewicz M, Wójcicki M, Nowacki P, Milkiewicz P. Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study. BMC Gastroenterol 2013;13:107. [PMID: 23815160 DOI: 10.1186/1471-230X-13-107] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
66 Wouters ATB, Wouters F, Boabaid FM, Watanabe TTN, Fredo G, Varaschin MS, Driemeier D. Brain lesions associated with acute toxic hepatopathy in cattle. J Vet Diagn Invest 2017;29:287-92. [PMID: 28363257 DOI: 10.1177/1040638717699242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Chavarria L, Romero-Giménez J, Monteagudo E, Lope-Piedrafita S, Cordoba J. Real-time assessment of ¹³C metabolism reveals an early lactate increase in the brain of rats with acute liver failure. NMR Biomed 2015;28:17-23. [PMID: 25303736 DOI: 10.1002/nbm.3226] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
68 Gao F, Li X, Wan G, Li Y, Zhang Q, Liu Y, Liu H, Li H, Wang X. Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis. BMC Gastroenterol. 2018;18:179. [PMID: 30509201 DOI: 10.1186/s12876-018-0911-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
69 Bajaj JS, Ridlon JM, Hylemon PB, Thacker LR, Heuman DM, Smith S, Sikaroodi M, Gillevet PM. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol. 2012;302:G168-G175. [PMID: 21940902 DOI: 10.1152/ajpgi.00190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Guan YS, He Q. Plants Consumption and Liver Health. Evid Based Complement Alternat Med 2015;2015:824185. [PMID: 26221179 DOI: 10.1155/2015/824185] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
71 Tanigami H, Okamoto T, Yasue Y, Shimaoka M. Astroglial integrins in the development and regulation of neurovascular units. Pain Res Treat 2012;2012:964652. [PMID: 23304493 DOI: 10.1155/2012/964652] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
72 Ahluwalia V, Wade JB, Thacker L, Kraft KA, Sterling RK, Stravitz RT, Fuchs M, Bouneva I, Puri P, Luketic V, Sanyal AJ, Gilles H, Heuman DM, Bajaj JS. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis. J Hepatol. 2013;59:467-473. [PMID: 23665182 DOI: 10.1016/j.jhep.2013.04.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
73 Häussinger D, Görg B. Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity. Curr Opin Clin Nutr Metab Care. 2010;13:87-92. [PMID: 19904201 DOI: 10.1097/mco.0b013e328333b829] [Cited by in Crossref: 88] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
74 Ahuja NK, Ally WA, Caldwell SH. Direct acting inhibitors of ammoniagenesis: a role in post-TIPS encephalopathy? Annals of Hepatology 2014;13:179-86. [DOI: 10.1016/s1665-2681(19)30880-4] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
75 Adlimoghaddam A, Albensi BC. The nuclear factor kappa B (NF-κB) signaling pathway is involved in ammonia-induced mitochondrial dysfunction. Mitochondrion 2021;57:63-75. [PMID: 33378713 DOI: 10.1016/j.mito.2020.12.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
76 Solà E, Ginès P. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol 2010;53:1135-45. [PMID: 20850887 DOI: 10.1016/j.jhep.2010.08.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
77 Lapraz JC, Hedayat KM. Endobiogeny: a global approach to systems biology (part 1 of 2). Glob Adv Health Med 2013;2:64-78. [PMID: 24381827 DOI: 10.7453/gahmj.2013.2.1.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Bélanger M, Magistretti PJ. The role of astroglia in neuroprotection. Dialogues Clin Neurosci 2009;11:281-95. [PMID: 19877496 [PMID: 19877496 DOI: 10.31887/dcns.2009.11.3/mbelanger] [Cited by in Crossref: 106] [Article Influence: 8.2] [Reference Citation Analysis]
79 Schulz C, Schütte K, Malfertheiner P. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review. J Clin Gastroenterol. 2014;48:491-499. [PMID: 24583758 DOI: 10.1097/mcg.0000000000000108] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
80 Sinha VK, Ko B. Hyponatremia in Cirrhosis--Pathogenesis, Treatment, and Prognostic Significance. Adv Chronic Kidney Dis 2015;22:361-7. [PMID: 26311597 DOI: 10.1053/j.ackd.2015.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
81 Zhang LJ, Zhong J, Lu GM. Multimodality MR imaging findings of low-grade brain edema in hepatic encephalopathy. AJNR Am J Neuroradiol. 2013;34:707-715. [PMID: 22383235 DOI: 10.3174/ajnr.a2968] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
82 Wang ZH, Liu P. Advance in roles of ammonia and cytokines in hepatic encephalopathy. Shijie Huaren Xiaohua Zazhi 2009; 17(16): 1638-1642 [DOI: 10.11569/wcjd.v17.i16.1638] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
83 Bergen WG, Wu G. Intestinal nitrogen recycling and utilization in health and disease. J Nutr. 2009;139:821-825. [PMID: 19282369 DOI: 10.3945/jn.109.104497] [Cited by in Crossref: 109] [Cited by in F6Publishing: 90] [Article Influence: 8.4] [Reference Citation Analysis]
84 Lutz P, Parcina M, Bekeredjian-Ding I, Nischalke HD, Nattermann J, Sauerbruch T, Hoerauf A, Strassburg CP, Spengler U. Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites. PLoS One. 2014;9:e93909. [PMID: 24714550 DOI: 10.1371/journal.pone.0093909] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
85 Rabinstein AA. Treatment of brain edema in acute liver failure. Curr Treat Options Neurol. 2010;12:129-141. [PMID: 20842576 DOI: 10.1007/s11940-010-0062-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
86 Riggio O, Ridola L. Emerging drugs for hepatic encephalopathy. Expert Opin Emerg Drugs 2009;14:537-49. [PMID: 19552607 DOI: 10.1517/14728210903055067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
87 Sundaram V, Shaikh OS. Hepatic encephalopathy: pathophysiology and emerging therapies. Med Clin North Am. 2009;93:819-836, vii. [PMID: 19577116 DOI: 10.1016/j.mcna.2009.03.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
88 Schiano TD. Clinical Management of Hepatic Encephalopathy. Pharmacotherapy 2010;30:10S-5S. [DOI: 10.1592/phco.30.pt2.10s] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
89 Minemura M, Shimizu Y. Gut microbiota and liver diseases. World J Gastroenterol 2015; 21(6): 1691-1702 [PMID: 25684933 DOI: 10.3748/wjg.v21.i6.1691] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 71] [Article Influence: 12.0] [Reference Citation Analysis]
90 Dufour DR. Liver Disease. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier; 2012. pp. 1637-93. [DOI: 10.1016/b978-1-4160-6164-9.00050-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
91 Oeltzschner G, Butz M, Baumgarten TJ, Hoogenboom N, Wittsack H, Schnitzler A. Low visual cortex GABA levels in hepatic encephalopathy: links to blood ammonia, critical flicker frequency, and brain osmolytes. Metab Brain Dis 2015;30:1429-38. [DOI: 10.1007/s11011-015-9729-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
92 Kushwah N, Jain V, Yadav D. Osmolytes: A Possible Therapeutic Molecule for Ameliorating the Neurodegeneration Caused by Protein Misfolding and Aggregation. Biomolecules 2020;10:E132. [PMID: 31941036 DOI: 10.3390/biom10010132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
93 Brandi G, de Rosa F, Calzà L, Girolamo SD, Tufoni M, Ricci CS, Cirignotta F, Caraceni P, Biasco G. Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients? Liver Int. 2013;33:488-493. [PMID: 23402614 DOI: 10.1111/liv.12102] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
94 Keitel V, Görg B, Bidmon HJ, Zemtsova I, Spomer L, Zilles K, Häussinger D. The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia. 2010;58:1794-1805. [PMID: 20665558 DOI: 10.1002/glia.21049] [Cited by in Crossref: 141] [Cited by in F6Publishing: 127] [Article Influence: 12.8] [Reference Citation Analysis]
95 Nikolov P, Baumgarten TJ, Hassan SS, Meissner SN, Füllenbach ND, Kircheis G, Häussinger D, Jördens MS, Butz M, Schnitzler A, Groiss SJ. Altered motor cortical plasticity in patients with hepatic encephalopathy: A paired associative stimulation study. Clin Neurophysiol 2021;132:2332-41. [PMID: 34454259 DOI: 10.1016/j.clinph.2021.07.019] [Reference Citation Analysis]
96 Zhang Z, Zhai H, Geng J, Yu R, Ren H, Fan H, Shi P. Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing. Am J Gastroenterol. 2013;108:1601-1611. [PMID: 23877352 DOI: 10.1038/ajg.2013.221] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
97 Oeltzschner G, Schnitzler A, Wickrath F, Zöllner HJ, Wittsack HJ. Use of quantitative brain water imaging as concentration reference for J-edited MR spectroscopy of GABA. Magn Reson Imaging 2016;34:1057-63. [PMID: 27109486 DOI: 10.1016/j.mri.2016.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Meijer AJ, Codogno P. Autophagy: Regulation and role in disease. Critical Reviews in Clinical Laboratory Sciences 2009;46:210-40. [DOI: 10.1080/10408360903044068] [Cited by in Crossref: 143] [Cited by in F6Publishing: 129] [Article Influence: 11.0] [Reference Citation Analysis]
99 Wilkinson DJ, Smeeton NJ, Watt PW. Ammonia metabolism, the brain and fatigue; revisiting the link. Prog Neurobiol. 2010;91:200-219. [PMID: 20138956 DOI: 10.1016/j.pneurobio.2010.01.012] [Cited by in Crossref: 91] [Cited by in F6Publishing: 81] [Article Influence: 7.6] [Reference Citation Analysis]
100 Dinc B, Aycan IO, Aslan M, Hadimioglu N, Ertug Z, Kisaoglu A, Demiryilmaz I. Evaluation of Preoperative and Postoperative S100β and NSE Levels in Liver Transplantation and Right Lobe Living-Donor Hepatectomy: A Prospective Cohort Study. Transplant Proc 2021;53:16-24. [PMID: 32605771 DOI: 10.1016/j.transproceed.2020.04.1818] [Reference Citation Analysis]
101 Bajaj JS, Ahluwalia V, Wade JB, Sanyal AJ, White MB, Noble NA, Monteith P, Fuchs M, Sterling RK, Luketic V, Bouneva I, Stravitz RT, Puri P, Kraft KA, Gilles H, Heuman DM. Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis. J Hepatol 2013;58:38-44. [PMID: 22889958 DOI: 10.1016/j.jhep.2012.08.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
102 Abe M, Soga T, Obana N, Seiji K, Tabata M, Saito N, Arita R, Numata T, Tanaka J, Kuroda H, Takayama S, Kagaya Y, Ishii T. Recommendation of Repeated Ammonia Tests for Intrahepatic Portal-Systemic Shunt Without Cirrhosis in Elderly Patients With Psychiatric Symptoms. Jpn Clin Med 2017;8:1179066017693597. [PMID: 28469525 DOI: 10.1177/1179066017693597] [Reference Citation Analysis]
103 Córdoba J, García-Martinez R, Simón-Talero M. Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence. Metab Brain Dis. 2010;25:73-80. [PMID: 20217202 DOI: 10.1007/s11011-010-9172-3] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
104 Ip YK, Chew SF. Ammonia production, excretion, toxicity, and defense in fish: a review. Front Physiol 2010;1:134. [PMID: 21423375 DOI: 10.3389/fphys.2010.00134] [Cited by in Crossref: 135] [Cited by in F6Publishing: 114] [Article Influence: 11.3] [Reference Citation Analysis]
105 Gkotsi D, Gupta M, Lascaratos G, Syrogiannis A, Dhillon B. Alcoholic liver disease and bilateral multifocal central serous retinopathy: a case report. J Med Case Rep 2013;7:43. [PMID: 23406548 DOI: 10.1186/1752-1947-7-43] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
106 Coltart I, Tranah TH, Shawcross DL. Inflammation and hepatic encephalopathy. Arch Biochem Biophys. 2013;536:189-196. [PMID: 23583306 DOI: 10.1016/j.abb.2013.03.016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
107 Karababa A, Görg B, Schliess F, Häussinger D. O-GlcNAcylation as a novel ammonia-induced posttranslational protein modification in cultured rat astrocytes. Metab Brain Dis 2014;29:975-82. [PMID: 24292976 DOI: 10.1007/s11011-013-9454-7] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
108 Cichoż-Lach H, Michalak A. Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. World J Gastroenterol 2013; 19(1): 26-34 [PMID: 23326159 DOI: 10.3748/wjg.v19.i1.26] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
109 Phatnani H, Maniatis T. Astrocytes in neurodegenerative disease. Cold Spring Harb Perspect Biol 2015;7:a020628. [PMID: 25877220 DOI: 10.1101/cshperspect.a020628] [Cited by in Crossref: 163] [Cited by in F6Publishing: 144] [Article Influence: 23.3] [Reference Citation Analysis]
110 Oria M, Romero-Giménez J, Arranz JA, Riudor E, Raguer N, Córdoba J. Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis. J Hepatol 2012;56:109-14. [PMID: 21835138 DOI: 10.1016/j.jhep.2011.06.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
111 Niknahad H, Jamshidzadeh A, Heidari R, Zarei M, Ommati MM. Ammonia-induced mitochondrial dysfunction and energy metabolism disturbances in isolated brain and liver mitochondria, and the effect of taurine administration: relevance to hepatic encephalopathy treatment. Clin Exp Hepatol 2017;3:141-51. [PMID: 29062904 DOI: 10.5114/ceh.2017.68833] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
112 Huang LT, Chen CC, Sheen JM, Chen YJ, Hsieh CS, Tain YL. The interaction between high ammonia diet and bile duct ligation in developing rats: assessment by spatial memory and asymmetric dimethylarginine. Int J Dev Neurosci 2010;28:169-74. [PMID: 19941949 DOI: 10.1016/j.ijdevneu.2009.11.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
113 Singh S, Mondal P, Trigun SK. Acute liver failure in rats activates glutamine-glutamate cycle but declines antioxidant enzymes to induce oxidative stress in cerebral cortex and cerebellum. PLoS One 2014;9:e95855. [PMID: 24755687 DOI: 10.1371/journal.pone.0095855] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
114 Iwasa M, Takei Y. Pathophysiology and management of hepatic encephalopathy 2014 update: Ammonia toxicity and hyponatremia: Management of hepatic encephalopathy. Hepatol Res 2015;45:1155-62. [DOI: 10.1111/hepr.12495] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
115 Bajaj JS, Gillevet PM, Patel NR, Ahluwalia V, Ridlon JM, Kettenmann B, Schubert CM, Sikaroodi M, Heuman DM, Crossey MM. A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metab Brain Dis. 2012;27:205-215. [PMID: 22527995 DOI: 10.1007/s11011-012-9303-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
116 Brusilow SW, Koehler RC, Traystman RJ, Cooper AJ. Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 2010;7:452-70. [PMID: 20880508 DOI: 10.1016/j.nurt.2010.05.015] [Cited by in Crossref: 125] [Cited by in F6Publishing: 115] [Article Influence: 11.4] [Reference Citation Analysis]
117 Grover VP, Tognarelli JM, Massie N, Crossey MM, Cook NA, Taylor-Robinson SD. The why and wherefore of hepatic encephalopathy. Int J Gen Med 2015;8:381-90. [PMID: 26719720 DOI: 10.2147/IJGM.S86854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
118 Biselli M, Dall'agata M, Gramenzi A, Gitto S, Liberati C, Brodosi L, Ravaioli M, Gambato M, Montalti R, Pinna AD, Burra P, Gerunda GE, Cillo U, Andreone P, Bernardi M. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. Liver Int 2015;35:184-91. [DOI: 10.1111/liv.12538] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
119 Allampati S, Mullen KD. Hepatic Encephalopathy. Handbook of Liver Disease. Elsevier; 2018. pp. 207-16. [DOI: 10.1016/b978-0-323-47874-8.00015-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
120 Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol 2021;75 Suppl 1:S49-66. [PMID: 34039492 DOI: 10.1016/j.jhep.2021.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
121 Hsu CY, Lee FY, Huo TI, Chan CY, Huang HC, Lin HC, Chang CC, Teng TH, Wang SS, Lee SD. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure. J Gastroenterol Hepatol 2010;25:1321-8. [PMID: 20594263 DOI: 10.1111/j.1440-1746.2010.06235.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
122 Minemura M, Tajiri K, Shimizu Y. Systemic abnormalities in liver disease. World J Gastroenterol 2009; 15(24): 2960-2974 [PMID: 19554648 DOI: 10.3748/wjg.15.2960] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
123 Mardini H, Record C. Pathogenesis of hepatic encephalopathy: lessons from nitrogen challenges in man. Metab Brain Dis. 2013;28:201-207. [PMID: 23180318 DOI: 10.1007/s11011-012-9362-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
124 Görg B, Bidmon HJ, Häussinger D. Gene expression profiling in the cerebral cortex of patients with cirrhosis with and without hepatic encephalopathy. Hepatology. 2013;57:2436-2447. [PMID: 23325665 DOI: 10.1002/hep.26265] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
125 Bismuth M, Funakoshi N, Cadranel JF, Blanc P. Hepatic encephalopathy: from pathophysiology to therapeutic management. Eur J Gastroenterol Hepatol. 2011;23:8-22. [PMID: 21099434 DOI: 10.1097/meg.0b013e3283417567] [Cited by in Crossref: 60] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
126 Zhang M, Duan ZJ. Retrospective analysis of factors influencing the development and progression of hepatic encephalopathy in patients with hepatitis B virus-related cirrhosis. Shijie Huaren Xiaohua Zazhi 2012; 20(13): 1148-1155 [DOI: 10.11569/wcjd.v20.i13.1148] [Reference Citation Analysis]
127 Bodega G, Segura B, Ciordia S, Mena Mdel C, López-Fernández LA, García MI, Trabado I, Suárez I. Ammonia Affects Astroglial Proliferation in Culture. PLoS One 2015;10:e0139619. [PMID: 26421615 DOI: 10.1371/journal.pone.0139619] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
128 Wilson CS, Mongin AA. Cell Volume Control in Healthy Brain and Neuropathologies. Curr Top Membr 2018;81:385-455. [PMID: 30243438 DOI: 10.1016/bs.ctm.2018.07.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
129 Wang QM, Ji Q, Duan ZJ, Zhang M, Chang QY. A study on the position and etiology of infection in cirrhotic patients: A potential precipitating factor contributing to hepatic encephalopathy. Exp Ther Med 2013;6:584-90. [PMID: 24137231 DOI: 10.3892/etm.2013.1137] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
130 Alonso J, Córdoba J, Rovira A. Brain magnetic resonance in hepatic encephalopathy. Semin Ultrasound CT MR. 2014;35:136-152. [PMID: 24745889 DOI: 10.1053/j.sult.2013.09.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
131 Mantry PS, Munsaf S. Rifaximin for the treatment of hepatic encephalopathy. Transplant Proc. 2010;42:4543-4547. [PMID: 21168733 DOI: 10.1016/j.transproceed.2010.09.173] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
132 Zemtsova I, Görg B, Keitel V, Bidmon HJ, Schrör K, Häussinger D. Microglia activation in hepatic encephalopathy in rats and humans. Hepatology. 2011;54:204-215. [PMID: 21452284 DOI: 10.1002/hep.24326] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 8.0] [Reference Citation Analysis]
133 Lachmann V, Görg B, Bidmon HJ, Keitel V, Häussinger D. Precipitants of hepatic encephalopathy induce rapid astrocyte swelling in an oxidative stress dependent manner. Arch Biochem Biophys. 2013;536:143-151. [PMID: 23707757 DOI: 10.1016/j.abb.2013.05.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
134 Milewski K, Oria M. What we know: the inflammatory basis of hepatic encephalopathy. Metab Brain Dis 2016;31:1239-47. [PMID: 26497651 DOI: 10.1007/s11011-015-9740-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
135 Frade MT, Ferreira JS, Nascimento MJ, Aquino VV, Macêdo IL, Carneiro RS, Souza AP, Dantas AF. Doenças do sistema nervoso central em cães. Pesq Vet Bras 2018;38:935-48. [DOI: 10.1590/1678-5150-pvb-5100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
136 Holte K, Krag A, Gluud LL. Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy. Hepatol Res 2012;42:1008-15. [PMID: 22548675 DOI: 10.1111/j.1872-034X.2012.01015.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
137 Häussinger D, Butz M, Schnitzler A, Görg B. Pathomechanisms in hepatic encephalopathy. Biol Chem 2021;402:1087-102. [PMID: 34049427 DOI: 10.1515/hsz-2021-0168] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
138 Moon J, Jun DW, Yum M, Lee KN, Lee HL, Lee OY, Yoon BC, Choi HS, Hahm JS, Seol IJ, Oh J, Kim C. Prolonged N200 is the early neurophysiologic change in the patient with minimal hepatic encephalopathy. Scandinavian Journal of Gastroenterology 2014;49:604-10. [DOI: 10.3109/00365521.2013.878382] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
139 Degos B, Daelman L, Huberfeld G, Meppiel E, Rabier D, Galanaud D, Magis AS, Lyon-Caen O, Samuel D, Sedel F. Portosystemic shunts: an underdiagnosed but treatable cause of neurological and psychiatric disorders. J Neurol Sci 2012;321:58-64. [PMID: 22906583 DOI: 10.1016/j.jns.2012.07.050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
140 Shah AK, Kreibich CD, Amdam GV, Münch D. Metabolic enzymes in glial cells of the honeybee brain and their associations with aging, starvation and food response. PLoS One 2018;13:e0198322. [PMID: 29927967 DOI: 10.1371/journal.pone.0198322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
141 Golaszewski S, Langthaler PB, Schwenker K, Florea C, Christova M, Brigo F, Trinka E, Nardone R. Abnormal cortical synaptic plasticity in minimal hepatic encephalopathy. Brain Research Bulletin 2016;125:200-4. [DOI: 10.1016/j.brainresbull.2016.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
142 Crawford JM, Liu C. Liver and Biliary Tract. Robbins and Cotran Pathologic Basis of Disease. Elsevier; 2010. pp. 833-90. [DOI: 10.1016/b978-1-4377-0792-2.50023-7] [Cited by in Crossref: 10] [Article Influence: 0.8] [Reference Citation Analysis]
143 Cunniffe N, Munby H, Chan S, Saatci D, Edison E, Carpenter RHS, Massey D. Using saccades to diagnose covert hepatic encephalopathy. Metab Brain Dis 2015;30:821-8. [DOI: 10.1007/s11011-014-9647-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
144 Premkumar M, Dhiman RK. Update in Hepatic Encephalopathy. J Clin Exp Hepatol 2018;8:217-8. [PMID: 30302035 DOI: 10.1016/j.jceh.2018.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
145 Liu C, Wang YM, Fan K. Epidemiological and clinical features of hepatitis B virus related liver failure in China. World J Gastroenterol 2011; 17(25): 3054-3059 [PMID: 21799653 DOI: 10.3748/wjg.v17.i25.3054] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
146 Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA, Hafeezullah M, Bell DE, Sterling RK, Stravitz RT, Fuchs M, Luketic V, Sanyal AJ. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011;140:478-487.e1. [PMID: 20849805 DOI: 10.1053/j.gastro.2010.08.061] [Cited by in Crossref: 141] [Cited by in F6Publishing: 125] [Article Influence: 11.8] [Reference Citation Analysis]
147 Görg B, Qvartskhava N, Bidmon HJ, Palomero-Gallagher N, Kircheis G, Zilles K, Häussinger D. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology 2010;52:256-65. [PMID: 20583283 DOI: 10.1002/hep.23656] [Cited by in Crossref: 99] [Cited by in F6Publishing: 90] [Article Influence: 8.3] [Reference Citation Analysis]
148 Blasco-Algora S, Masegosa-Ataz J, Gutiérrez-García ML, Alonso-López S, Fernández-Rodríguez CM. Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management. World J Gastroenterol 2015; 21(42): 12125-12140 [PMID: 26576097 DOI: 10.3748/wjg.v21.i42.12125] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
149 Ozanne B, Nelson J, Cousineau J, Lambert M, Phan V, Mitchell G, Alvarez F, Ducruet T, Jouvet P. Threshold for toxicity from hyperammonemia in critically ill children. Journal of Hepatology 2012;56:123-8. [DOI: 10.1016/j.jhep.2011.03.021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
150 Kahlbrock N, Butz M, May ES, Brenner M, Kircheis G, Häussinger D, Schnitzler A. Lowered frequency and impaired modulation of gamma band oscillations in a bimodal attention task are associated with reduced critical flicker frequency. NeuroImage 2012;61:216-27. [DOI: 10.1016/j.neuroimage.2012.02.063] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
151 Chris-Olaiya A, Kapoor A, Ricci KS, Lindenmeyer CC. Therapeutic plasma exchange in liver failure. World J Hepatol 2021; 13(8): 904-915 [PMID: 34552697 DOI: 10.4254/wjh.v13.i8.904] [Reference Citation Analysis]
152 Cordoba J, Ventura-Cots M, Simón-Talero M, Amorós À, Pavesi M, Vilstrup H, Angeli P, Domenicali M, Ginés P, Bernardi M. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol. 2014;60:275-281. [PMID: 24128414 DOI: 10.1016/j.jhep.2013.10.004] [Cited by in Crossref: 161] [Cited by in F6Publishing: 140] [Article Influence: 17.9] [Reference Citation Analysis]
153 Hung TH, Lay CJ, Chang CM, Tsai JJ, Tsai CC, Tsai CC. The effect of infections on the mortality of cirrhotic patients with hepatic encephalopathy. Epidemiol Infect 2013;141:2671-8. [PMID: 23433300 DOI: 10.1017/S0950268813000186] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
154 . Liver. Canine and Feline Gastroenterology. Elsevier; 2013. pp. 849-957. [DOI: 10.1016/b978-1-4160-3661-6.00061-4] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
155 Waghray A, Waghray N, Mullen K. Management of covert hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S75-81. [PMID: 26041963 DOI: 10.1016/j.jceh.2014.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
156 Delic D, Warskulat U, Borsch E, Al-Qahtani S, Al-Quraishi S, Häussinger D, Wunderlich F. Loss of ability to self-heal malaria upon taurine transporter deletion. Infect Immun 2010;78:1642-9. [PMID: 20100858 DOI: 10.1128/IAI.01159-09] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
157 Parekh PJ, Balart LA. Ammonia and Its Role in the Pathogenesis of Hepatic Encephalopathy. Clin Liver Dis. 2015;19:529-537. [PMID: 26195206 DOI: 10.1016/j.cld.2015.05.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
158 Robinson AM, Karvellas CJ, Dionne JC, Featherstone R, Sebastianski M, Vandermeer B, Rewa OG. Continuous renal replacement therapy and transplant-free survival in acute liver failure: protocol for a systematic review and meta-analysis. Syst Rev 2020;9:143. [PMID: 32546277 DOI: 10.1186/s13643-020-01405-7] [Reference Citation Analysis]
159 Neff GW, Jones M, Broda T, Jonas M, Ravi R, Novick D, Kaiser TE, Kemmer N. Durability of rifaximin response in hepatic encephalopathy. J Clin Gastroenterol. 2012;46:168-171. [PMID: 22011586 DOI: 10.1097/mcg.0b013e318231faae] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
160 Oenarto J, Görg B, Moos M, Bidmon H, Häussinger D. Expression of organic osmolyte transporters in cultured rat astrocytes and rat and human cerebral cortex. Archives of Biochemistry and Biophysics 2014;560:59-72. [DOI: 10.1016/j.abb.2014.06.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
161 Hassan SS, Baumgarten TJ, Ali AM, Füllenbach N, Jördens MS, Häussinger D, Butz M, Schnitzler A, Groiss SJ. Cerebellar inhibition in hepatic encephalopathy. Clinical Neurophysiology 2019;130:886-92. [DOI: 10.1016/j.clinph.2019.02.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
162 Bruetto RG, Rodrigues FB, Torres US, Otaviano AP, Zanetta DM, Burdmann EA. Renal function at hospital admission and mortality due to acute kidney injury after myocardial infarction. PLoS One. 2012;7:e35496. [PMID: 22539974 DOI: 10.1371/journal.pone] [Cited by in F6Publishing: 90] [Reference Citation Analysis]
163 Hanai T, Shiraki M, Watanabe S, Kochi T, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatol Res. 2017;47:1359-1367. [PMID: 28199774 DOI: 10.1111/hepr.12873] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
164 Sato K, Arai N, Omori A, Hida A, Kimura A, Takeuchi S. Hyperammonaemia and associated factors in unprovoked convulsive seizures: A cross-sectional study. Seizure 2016;43:6-12. [PMID: 27768938 DOI: 10.1016/j.seizure.2016.09.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
165 McKinney AM, Lohman BD, Sarikaya B, Uhlmann E, Spanbauer J, Singewald T, Brace JR. Acute hepatic encephalopathy: diffusion-weighted and fluid-attenuated inversion recovery findings, and correlation with plasma ammonia level and clinical outcome. AJNR Am J Neuroradiol. 2010;31:1471-1479. [PMID: 20448015 DOI: 10.3174/ajnr.a2112] [Cited by in Crossref: 64] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
166 Cordoba J. Hepatic Encephalopathy: From the Pathogenesis to the New Treatments. ISRN Hepatol 2014;2014:236268. [PMID: 27335836 DOI: 10.1155/2014/236268] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
167 Kruczek C, Görg B, Keitel V, Bidmon HJ, Schliess F, Häussinger D. Ammonia increases nitric oxide, free Zn(2+), and metallothionein mRNA expression in cultured rat astrocytes. Biol Chem 2011;392:1155-65. [PMID: 22050230 DOI: 10.1515/BC.2011.199] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
168 Wilkinson DJ, Smeeton NJ, Castle PC, Watt PW. Absence of neuropsychological impairment in hyperammonaemia in healthy young adults; possible synergism in development of hepatic encephalopathy (HE) symptoms? Metab Brain Dis. 2011;26:203-212. [PMID: 21773808 DOI: 10.1007/s11011-011-9251-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
169 Nardone R, Taylor AC, Höller Y, Brigo F, Lochner P, Trinka E. Minimal hepatic encephalopathy: A review. Neurosci Res 2016;111:1-12. [PMID: 27153746 DOI: 10.1016/j.neures.2016.04.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
170 Duarte-Rojo A, Ruiz-Margáin A, Macias-Rodriguez RU, Cubero FJ, Estradas-Trujillo J, Muñoz-Fuentes RM, Torre A. Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy. World J Gastroenterol 2016; 22(17): 4397-4402 [PMID: 27158209 DOI: 10.3748/wjg.v22.i17.4397] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
171 Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A, Gmizic I, Stevanovic O, Djordjevic V, Lekic N, Russo E, Amedei A. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. Int J Mol Sci. 2019;20:395. [PMID: 30658519 DOI: 10.3390/ijms20020395] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 27.3] [Reference Citation Analysis]
172 Lambert IH, Hoffmann EK, Pedersen SF. Cell volume regulation: physiology and pathophysiology. Acta Physiologica 2008;194:255-82. [DOI: 10.1111/j.1748-1716.2008.01910.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
173 Livingstone C. Zinc: physiology, deficiency, and parenteral nutrition. Nutr Clin Pract 2015;30:371-82. [PMID: 25681484 DOI: 10.1177/0884533615570376] [Cited by in Crossref: 110] [Cited by in F6Publishing: 92] [Article Influence: 15.7] [Reference Citation Analysis]
174 Chavarria L, Oria M, Romero–gimenez J, Alonso J, Lope–piedrafita S, Cordoba J. Diffusion Tensor Imaging Supports the Cytotoxic Origin of Brain Edema in a Rat Model of Acute Liver Failure. Gastroenterology 2010;138:1566-73. [DOI: 10.1053/j.gastro.2009.10.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
175 Schroeter A, Wen S, Mölders A, Erlenhardt N, Stein V, Klöcker N. Depletion of the AMPAR reserve pool impairs synaptic plasticity in a model of hepatic encephalopathy. Molecular and Cellular Neuroscience 2015;68:331-9. [DOI: 10.1016/j.mcn.2015.09.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
176 Oeltzschner G, Butz M, Wickrath F, Wittsack H, Schnitzler A. Covert hepatic encephalopathy: elevated total glutathione and absence of brain water content changes. Metab Brain Dis 2016;31:517-27. [DOI: 10.1007/s11011-015-9760-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
177 Neff GW, Jones M, Jonas M, Ravinuthala R, Novick D, Kaiser TE, Kemmer N. Lack of Clostridium difficile infection in patients treated with rifaximin for hepatic encephalopathy: a retrospective analysis. J Clin Gastroenterol. 2013;47:188-192. [PMID: 23314671 DOI: 10.1097/MCG.0b013e318276be13] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
178 Hansen DB, Friis MB, Hoffmann EK, Lambert IH. Downregulation of the taurine transporter TauT during hypo-osmotic stress in NIH3T3 mouse fibroblasts. J Membr Biol 2012;245:77-87. [PMID: 22383044 DOI: 10.1007/s00232-012-9416-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
179 Karababa A, Groos-Sahr K, Albrecht U, Keitel V, Shafigullina A, Görg B, Häussinger D. Ammonia Attenuates LPS-Induced Upregulation of Pro-Inflammatory Cytokine mRNA in Co-Cultured Astrocytes and Microglia. Neurochem Res 2017;42:737-49. [PMID: 27655254 DOI: 10.1007/s11064-016-2060-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
180 Alimirah M, Sadiq O, Gordon SC. Novel Therapies in Hepatic Encephalopathy. Clin Liver Dis 2020;24:303-15. [PMID: 32245535 DOI: 10.1016/j.cld.2020.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Zhang YB. Progress in understanding the pathogenesis of hepatic encephalopathy. Shijie Huaren Xiaohua Zazhi 2012; 20(25): 2358-2363 [DOI: 10.11569/wcjd.v20.i25.2358] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Spodenkiewicz M, Diez-Fernandez C, Rüfenacht V, Gemperle-Britschgi C, Häberle J. Minireview on Glutamine Synthetase Deficiency, an Ultra-Rare Inborn Error of Amino Acid Biosynthesis. Biology (Basel) 2016;5:E40. [PMID: 27775558 DOI: 10.3390/biology5040040] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
183 Dadsetan S, Kukolj E, Bak LK, Sørensen M, Ott P, Vilstrup H, Schousboe A, Keiding S, Waagepetersen HS. Brain alanine formation as an ammonia-scavenging pathway during hyperammonemia: effects of glutamine synthetase inhibition in rats and astrocyte-neuron co-cultures. J Cereb Blood Flow Metab 2013;33:1235-41. [PMID: 23673435 DOI: 10.1038/jcbfm.2013.73] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
184 Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010;7:515-25. [DOI: 10.1038/nrgastro.2010.116] [Cited by in Crossref: 174] [Cited by in F6Publishing: 152] [Article Influence: 14.5] [Reference Citation Analysis]
185 Chacko KR, Sigal SH. Update on management of patients with overt hepatic encephalopathy. Hosp Pract (1995) 2013;41:48-59. [PMID: 23948621 DOI: 10.3810/hp.2013.08.1068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
186 Zhang XD, Zhang LJ, Wu SY, Lu GM. Multimodality magnetic resonance imaging in hepatic encephalopathy: An update. World J Gastroenterol 2014; 20(32): 11262-11272 [PMID: 25170210 DOI: 10.3748/wjg.v20.i32.11262] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
187 Gianotti RJ, Cardenas A. Hyponatraemia and cirrhosis. Gastroenterol Rep (Oxf) 2014;2:21-6. [PMID: 24760233 DOI: 10.1093/gastro/got037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
188 Rodriguez-Madoz JR, Liu KH, Quetglas JI, Ruiz-Guillen M, Otano I, Crettaz J, Butler SD, Bellezza CA, Dykes NL, Tennant BC, Prieto J, González-Aseguinolaza G, Smerdou C, Menne S. Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma. J Virol 2009;83:12266-78. [PMID: 19740992 DOI: 10.1128/JVI.01597-09] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
189 Sidhu SS, Sharma BC, Goyal O, Kishore H, Kaur N. L-ornithine L-aspartate in bouts of overt hepatic encephalopathy. Hepatology. 2017;. [PMID: 28749571 DOI: 10.1002/hep.29410] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
190 Mullen K, Prakash R. Rifaximin for the treatment of hepatic encephalopathy. Expert Rev Gastroenterol Hepatol 2010;4:665-77. [PMID: 21108586 DOI: 10.1586/egh.10.78] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
191 Chavez-Tapia NC, Cesar-Arce A, Barrientos-Gutiérrez T, Villegas-López FA, Méndez-Sanchez N, Uribe M. A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy. Nutr J. 2013;12:74. [PMID: 23742732 DOI: 10.1186/1475-2891-12-74] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
192 Lam SY, Liu Y, Ng KM, Lau CF, Liong EC, Tipoe GL, Fung ML. Chronic intermittent hypoxia induces local inflammation of the rat carotid body via functional upregulation of proinflammatory cytokine pathways. Histochem Cell Biol. 2012;137:303-317. [PMID: 22187044 DOI: 10.1007/s00418-011-0900-5] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 6.5] [Reference Citation Analysis]
193 Qvartskhava N, Lang PA, Görg B, Pozdeev VI, Ortiz MP, Lang KS, Bidmon HJ, Lang E, Leibrock CB, Herebian D, Bode JG, Lang F, Häussinger D. Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase. Proc Natl Acad Sci U S A 2015;112:5521-6. [PMID: 25870278 DOI: 10.1073/pnas.1423968112] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
194 Schliess F, Görg B, Häussinger D. RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia. Metab Brain Dis 2009;24:119-34. [DOI: 10.1007/s11011-008-9125-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
195 Harris MK, Elliott D, Schwendimann RN, Minagar A, Jaffe SL. Neurologic Presentations of Hepatic Disease. Neurologic Clinics 2010;28:89-105. [DOI: 10.1016/j.ncl.2009.09.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
196 Garcia-martinez R, Cordoba J. Liver-induced inflammation hurts the brain. Journal of Hepatology 2012;56:515-7. [DOI: 10.1016/j.jhep.2011.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
197 Bloom A, Bloom S, Silva H, Nicoll AJ, Sawhney R. Zinc supplementation and its benefits in the management of chronic liver disease: An in-depth literature review. Ann Hepatol 2021;25:100549. [PMID: 34614431 DOI: 10.1016/j.aohep.2021.100549] [Reference Citation Analysis]
198 Dominguini D, Dall'igna DM, Nogueira L, Steckert AV, GonÇalves RC, Michels M, Quevedo J, Ritter C, Barichello T, Dal-Pizzol F. Ammonia exposition during gestation induces neonatal oxidative damage in the brain and long-term cognitive alteration in rats. An Acad Bras Cienc 2020;92:e20190925. [PMID: 33295575 DOI: 10.1590/0001-3765202020190925] [Reference Citation Analysis]
199 Taniguchi E, Kawaguchi T, Sakata M, Itou M, Oriishi T, Sata M. Lipid profile is associated with the incidence of cognitive dysfunction in viral cirrhotic patients: A data-mining analysis: Cognition-related lipid profile in liver cirrhosis. Hepatology Research 2013;43:418-24. [DOI: 10.1111/j.1872-034x.2012.01076.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
200 Zöllner HJ, Butz M, Jördens M, Füllenbach ND, Häussinger D, Schmitt B, Wittsack HJ, Schnitzler A. Chemical exchange saturation transfer imaging in hepatic encephalopathy. Neuroimage Clin 2019;22:101743. [PMID: 30856541 DOI: 10.1016/j.nicl.2019.101743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
201 Lee A, Lingwood BE, Bjorkman ST, Miller SM, Poronnik P, Barnett NL, Colditz P, Pow DV. Rapid loss of glutamine synthetase from astrocytes in response to hypoxia: Implications for excitotoxicity. Journal of Chemical Neuroanatomy 2010;39:211-20. [DOI: 10.1016/j.jchemneu.2009.12.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
202 Assimakopoulos SF, Gogos C, Labropoulou-karatza C. Could antioxidants be the “magic pill” for cirrhosis-related complications? A pathophysiological appraisal. Medical Hypotheses 2011;77:419-23. [DOI: 10.1016/j.mehy.2011.05.034] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
203 Rodrigo R, Cauli O, Boix J, Elmlili N, Agusti A, Felipo V. Role of NMDA receptors in acute liver failure and ammonia toxicity: Therapeutical implications. Neurochemistry International 2009;55:113-8. [DOI: 10.1016/j.neuint.2009.01.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
204 Heidari R. Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy. Life Sciences 2019;218:65-80. [DOI: 10.1016/j.lfs.2018.12.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
205 Manka P, Bechmann LP, Tacke F, Sowa JP, Schlattjan M, Kälsch J, Jochum C, Paul A, Saner FH, Trautwein C, Gerken G, Canbay A. Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure. BMC Gastroenterol 2013;13:58. [PMID: 23551795 DOI: 10.1186/1471-230X-13-58] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
206 Riggio O, Amodio P, Farcomeni A, Merli M, Nardelli S, Pasquale C, Pentassuglio I, Gioia S, Onori E, Piazza N. A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2015;13:1346-1352. [PMID: 25572976 DOI: 10.1016/j.cgh.2014.12.025] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
207 Weissenborn K. Portosystemic encephalopathy. Neurologic Aspects of Systemic Disease Part II. Elsevier; 2014. pp. 661-74. [DOI: 10.1016/b978-0-7020-4087-0.00045-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
208 Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial. Hepatology 2021. [PMID: 34822189 DOI: 10.1002/hep.32255] [Reference Citation Analysis]
209 Blauenfeldt RA, Olesen SS, Hansen JB, Graversen C, Drewes AM. Abnormal brain processing in hepatic encephalopathy: evidence of cerebral reorganization? Eur J Gastroenterol Hepatol 2010;22:1323-30. [PMID: 20661140 DOI: 10.1097/MEG.0b013e32833d4717] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
210 Jindal A, Jagdish RK. Sarcopenia: Ammonia metabolism and hepatic encephalopathy. Clin Mol Hepatol. 2019;. [PMID: 31006226 DOI: 10.3350/cmh.2019.0015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
211 Suraweera D, Sundaram V, Saab S. Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions. Gut Liver. 2016;10:509-519. [PMID: 27377741 DOI: 10.5009/gnl15419] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
212 Tsai CY, Su CH, Chan JY, Chan SH. Nitrosative Stress-Induced Disruption of Baroreflex Neural Circuits in a Rat Model of Hepatic Encephalopathy: A DTI Study. Sci Rep 2017;7:40111. [PMID: 28079146 DOI: 10.1038/srep40111] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
213 Fukui H. Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites? World J Gastroenterol 2015; 21(41): 11584-11596 [PMID: 26556988 DOI: 10.3748/wjg.v21.i41.11584] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
214 Bajaj JS, Ridlon JM, Hylemon PB, Thacker LR, Heuman DM, Smith S, Sikaroodi M, Gillevet PM. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol. 2012;302:G168-G175. [PMID: 21940902 DOI: 10.1152/ajpgi.00190.2011] [Cited by in Crossref: 292] [Cited by in F6Publishing: 281] [Article Influence: 26.5] [Reference Citation Analysis]
215 Sidhu SS, Goyal O, Parker RA, Kishore H, Sood A. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy. Liver Int. 2016;36:378-385. [PMID: 26201713 DOI: 10.1111/liv.12921] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
216 Dhanda S, Sandhir R. Role of dopaminergic and serotonergic neurotransmitters in behavioral alterations observed in rodent model of hepatic encephalopathy. Behav Brain Res 2015;286:222-35. [PMID: 25639545 DOI: 10.1016/j.bbr.2015.01.042] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
217 Li M, Zhang Z, Chen Q, Zhou X, Shui D, Huang J. Comparative Effectiveness and Safety of Polyethylene Glycol Electrolyte Solution Versus Lactulose for Treatment of Hepatic Encephalopathy: A Systematic Review and Meta-analysis. J Clin Gastroenterol 2022;56:41-8. [PMID: 34739404 DOI: 10.1097/MCG.0000000000001621] [Reference Citation Analysis]
218 Sergeeva OA. GABAergic transmission in hepatic encephalopathy. Arch Biochem Biophys. 2013;536:122-130. [PMID: 23624382 DOI: 10.1016/j.abb.2013.04.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
219 Bobermin LD, Wartchow KM, Flores MP, Leite MC, Quincozes-Santos A, Gonçalves CA. Ammonia-induced oxidative damage in neurons is prevented by resveratrol and lipoic acid with participation of heme oxygenase 1. Neurotoxicology 2015;49:28-35. [PMID: 26003724 DOI: 10.1016/j.neuro.2015.05.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
220 Simón-Talero M, García-Martínez R, Torrens M, Augustin S, Gómez S, Pereira G, Guevara M, Ginés P, Soriano G, Román E. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. J Hepatol. 2013;59:1184-1192. [PMID: 23872605 DOI: 10.1016/j.jhep.2013.07.020] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
221 Zeng B, Sun L, Chen Y, Qian Y, Cao Q, Zhang Z, Li Z. Neisseria flavescens: A Urease-Expressing Potential Pathogen Isolated from Gastritis Patients. Curr Microbiol 2018;75:186-93. [PMID: 29063969 DOI: 10.1007/s00284-017-1364-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
222 Patel D, Mcphail M, Cobbold J, Taylor-robinson S. Hepatic encephalopathy. British Journal of Hospital Medicine 2012;73:79-85. [DOI: 10.12968/hmed.2012.73.2.79] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
223 Is B, Bombassaro IZ, Tovo CV, de Mattos ÂZ, Ahlert M, Chiesa T, de Mattos AA. Albumin in the management of hepatic encephalopathy: A systematic review and meta-analysis. Ann Hepatol 2021;26:100541. [PMID: 34600143 DOI: 10.1016/j.aohep.2021.100541] [Reference Citation Analysis]
224 Jalan R, De Chiara F, Balasubramaniyan V, Andreola F, Khetan V, Malago M, Pinzani M, Mookerjee RP, Rombouts K. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension. J Hepatol. 2016;64:823-833. [PMID: 26654994 DOI: 10.1016/j.jhep.2015.11.019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]